Company Data

Rallybio Corporation

Ticker
RLYB
Current Price
$0.309 -3.13%
Market Cap
$12.9M
Price Target
Refer to Report
Volume
34.7K
52wk Range
$0.2201 - $1.7291
Advanced Market Data

Overview

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy